Ganga Pharmaceuticals Fair Value

Fair Value Analysis Export

P/E Based Valuation

Current EPS ₹0.1

Sector Avg P/E 20.5

Historical Avg P/E N/A

Average Fair Value

₹1.85

P/B Based Valuation

Book Value/Share ₹13.33

Sector Avg P/B 4.36

Historical Avg P/B N/A

Average Fair Value

₹39.06

Asset-Based Valuation

Book Value/Share ₹13.33

Liquidation Value/Share ₹11.67

Fair Value

₹13.33

Benjamin Graham Number

Current EPS ₹0.1

Book Value/Share ₹13.33

Graham Multiplier 22.5

Current P/E 488.2

Graham Criteria 1/3

Graham Number

₹5.48

Criteria Met: P/B ≤ 1.5

GANGAPHARM Fair Value Analysis — Data Sources & Coverage

Ganga Pharmaceuticals financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit Ganga Pharmaceuticals screener.

Methods Used

Sector

Healthcare

Available Data Sources: Financial statements, balance sheet data , sector comparisons.

GANGAPHARM vs Healthcare Sector Peers — P/E, P/B & Market Cap

Ganga Pharmaceuticals P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company	Symbol	P/E Ratio	P/B Ratio	Market Cap (₹ Cr)
Emcure Pharmaceuticals	EMCURE	35.85	7.38	₹37,156
Syngene International	SYNGENE	68.69	3.13	₹15,000
Sat Kartar Life	SATKARTAR	16.56	4.14	₹307
Divis Laboratories	DIVISLAB	87.22	15.22	₹253,522
Aurobindo Pharma	AUROPHARMA	25.97	2.54	₹96,479

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.